SYDNEY DANTZLER: Open Payments
NPI 1396380721 · SWANSEA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 12 payments from 7 companies in 2025. Trend: 2023 $137 · 2024 $235 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $104 |
| Exact Sciences Corporation | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: VRAYLAR, Cologuard Collection Kit, GEMTESA, MOUNJARO, Ozempic, CAPLYTA, PREVNAR 20.
Industry payments across SC — which companies pay providers there.
